Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Rubin

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Gynecologic Oncology|October 1, 1993
Biodistribution and intraoperative evaluation of radiolabeled monoclonal antibody MX35 in patients with epithelial ovarian cancerS C Rubin, L Kostakoglu, C Divgi, et al.
Gynecologic Oncology|June 11, 1992
Management of vulvar melanomaE L Trimble, J L Lewis, L L Williams, et al.
Gynecologic Oncology|August 11, 1991
Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapyS C Rubin, W J Hoskins, P E Saigo, et al.
Gynecologic Oncology|September 1, 1989
Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinomaW J Hoskins, S C Rubin, E Dulaney, et al.
Journal of Consulting and Clinical Psychology|April 1, 1990
Anticipatory immune suppression and nausea in women receiving cyclic chemotherapy for ovarian cancerD H Bovbjerg, W H Redd, L A Maier, et al.
Gynecologic Oncology|June 11, 1992
Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinomaT B Hakes, E Chalas, W J Hoskins, et al.
Cancer Gene Therapy|April 19, 2000
Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapyG Coukos, A Makrigiannakis, S Montas, et al.
Gynecologic Oncology|September 1, 1990
Aggressive chemosurgical debulking in patients with advanced ovarian cancerL W Ng, S C Rubin, W J Hoskins, et al.
Cancer Research|June 19, 2001
Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancerE Y Woo, C S Chu, T J Goletz, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 11, 1990
Immunohistochemical localization of P-glycoprotein in adult human ovary and female genital tract of patients with benign gynecological conditionsC L Finstad, P E Saigo, S C Rubin, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Gynecologic Oncology|October 1, 1993
Biodistribution and intraoperative evaluation of radiolabeled monoclonal antibody MX35 in patients with epithelial ovarian cancerS C Rubin, L Kostakoglu, C Divgi, et al.
Gynecologic Oncology|June 11, 1992
Management of vulvar melanomaE L Trimble, J L Lewis, L L Williams, et al.
Gynecologic Oncology|August 11, 1991
Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapyS C Rubin, W J Hoskins, P E Saigo, et al.
Gynecologic Oncology|September 1, 1989
Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinomaW J Hoskins, S C Rubin, E Dulaney, et al.
Journal of Consulting and Clinical Psychology|April 1, 1990
Anticipatory immune suppression and nausea in women receiving cyclic chemotherapy for ovarian cancerD H Bovbjerg, W H Redd, L A Maier, et al.
Gynecologic Oncology|June 11, 1992
Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinomaT B Hakes, E Chalas, W J Hoskins, et al.
Cancer Gene Therapy|April 19, 2000
Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapyG Coukos, A Makrigiannakis, S Montas, et al.
Gynecologic Oncology|September 1, 1990
Aggressive chemosurgical debulking in patients with advanced ovarian cancerL W Ng, S C Rubin, W J Hoskins, et al.
Cancer Research|June 19, 2001
Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancerE Y Woo, C S Chu, T J Goletz, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 11, 1990
Immunohistochemical localization of P-glycoprotein in adult human ovary and female genital tract of patients with benign gynecological conditionsC L Finstad, P E Saigo, S C Rubin, et al.
Pageof 13